BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22473595)

  • 1. Cancer of unknown primary (CUP): does cause of death and family history implicate hidden phenotypically changed primaries?
    Hemminki K; Bevier M; Sundquist J; Hemminki A
    Ann Oncol; 2012 Oct; 23(10):2720-2724. PubMed ID: 22473595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer.
    Riihimäki M; Thomsen H; Hemminki A; Sundquist K; Hemminki K
    BMC Cancer; 2013 Jan; 13():36. PubMed ID: 23356713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Location of metastases in cancer of unknown primary are not random and signal familial clustering.
    Hemminki K; Sundquist K; Sundquist J; Hemminki A; Ji J
    Sci Rep; 2016 Mar; 6():22891. PubMed ID: 26956545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causes of death in patients with extranodal cancer of unknown primary: searching for the primary site.
    Riihimäki M; Hemminki A; Sundquist K; Hemminki K
    BMC Cancer; 2014 Jun; 14():439. PubMed ID: 24929562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific cancer deaths in cancer of unknown primary diagnosed with lymph node metastasis may reveal hidden primaries.
    Hemminki K; Bevier M; Sundquist J; Hemminki A
    Int J Cancer; 2013 Feb; 132(4):944-50. PubMed ID: 22730111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second primary cancers after cancer of unknown primary in Sweden and Germany: efficacy of the modern work-up.
    Liu H; Hemminki K; Sundquist J; Holleczek B; Katalinic A; Emrich K; Brenner H;
    Eur J Cancer Prev; 2013 May; 22(3):210-4. PubMed ID: 22960777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time trends in survival from cancer of unknown primary: small steps forward.
    Riihimäki M; Hemminki A; Sundquist K; Hemminki K
    Eur J Cancer; 2013 Jul; 49(10):2403-10. PubMed ID: 23518210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: a systematic literature review.
    Pentheroudakis G; Greco FA; Pavlidis N
    Cancer Treat Rev; 2009 May; 35(3):221-7. PubMed ID: 19046817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial cancer of unknown primary.
    Rassy E; Kattan J; Pavlidis N
    Int J Clin Oncol; 2019 Oct; 24(10):1328-1331. PubMed ID: 31203526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial risks in cancer of unknown primary: tracking the primary sites.
    Hemminki K; Ji J; Sundquist J; Shu X
    J Clin Oncol; 2011 Feb; 29(4):435-40. PubMed ID: 21189391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-specific survival rates for cancer of unknown primary according to location of metastases.
    Hemminki K; Riihimäki M; Sundquist K; Hemminki A
    Int J Cancer; 2013 Jul; 133(1):182-9. PubMed ID: 23233409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of cancer of unknown primary in Sweden: analysis by location of metastasis.
    Bevier M; Sundquist J; Hemminki K
    Eur J Cancer Prev; 2012 Nov; 21(6):596-601. PubMed ID: 22387673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subsequent cancers in patients diagnosed with cancer of unknown primary (CUP): etiological insights?
    Shu X; Liu H; Ji J; Sundquist K; Försti A; Sundquist J; Hemminki K
    Ann Oncol; 2012 Jan; 23(1):269-275. PubMed ID: 21450937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-Dependent Metastatic Spread and Survival: Cancer of Unknown Primary as a Model.
    Hemminki K; Pavlidis N; Tsilidis KK; Sundquist K; Ji J
    Sci Rep; 2016 Mar; 6():23725. PubMed ID: 27009354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial Risk in Patients With Carcinoma of Unknown Primary.
    Samadder NJ; Smith KR; Hanson H; Pimentel R; Wong J; Boucher K; Akerley W; Gilcrease G; Ulrich CM; Burt RW; Curtin K
    JAMA Oncol; 2016 Mar; 2(3):340-6. PubMed ID: 26863281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Power and limits of modern cancer diagnostics: cancer of unknown primary.
    Hemminki K; Liu H; Heminki A; Sundquist J
    Ann Oncol; 2012 Mar; 23(3):760-764. PubMed ID: 21821544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer patients without a known primary: incidence and survival trends in Sweden 1960-2007.
    Randén M; Rutqvist LE; Johansson H
    Acta Oncol; 2009; 48(6):915-20. PubMed ID: 19363713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time trends in incidence, causes of death, and survival of cancer of unknown primary in Sweden.
    Shu X; Sundquist K; Sundquist J; Hemminki K
    Eur J Cancer Prev; 2012 May; 21(3):281-8. PubMed ID: 21968687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline genetics of cancer of unknown primary (CUP) and its specific subtypes.
    Hemminki K; Chen B; Kumar A; Melander O; Manjer J; Hallmans G; Pettersson-Kymmer U; Ohlsson C; Folprecht G; Löffler H; Krämer A; Försti A
    Oncotarget; 2016 Apr; 7(16):22140-9. PubMed ID: 26959888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.